Multidisciplinary Care of Neurosurgical Patients with Genetic Syndromes.

Genetic syndromes Interdisciplinary Multidisciplinary Skeletal dysplasia Team-based care

Journal

Neurosurgery clinics of North America
ISSN: 1558-1349
Titre abrégé: Neurosurg Clin N Am
Pays: United States
ID NLM: 9008004

Informations de publication

Date de publication:
Jan 2022
Historique:
entrez: 21 11 2021
pubmed: 22 11 2021
medline: 24 11 2021
Statut: ppublish

Résumé

Neurosurgical patients with genetic syndromes often receive care from multidisciplinary teams. Successful models range from multiple providers in one clinic space seeing a patient together to specialists located at different institutions working together. Collaboration and bidirectional communication are key. Multidisciplinary care improves outcomes and patient satisfaction. Choosing the goal of the clinic, using ancillary staff, and obtaining institutional buy-in are important initial first steps to establishing a multidisciplinary team clinic. Multidisciplinary teams can leverage technology to expand care via telehealth in multidisciplinary clinics and more vitally communication between providers on the team.

Identifiants

pubmed: 34801144
pii: S1042-3680(21)00077-2
doi: 10.1016/j.nec.2021.09.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-15

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The following is a list of grants and funding. There are no conflicts of interest related to this article. R. Savarirayan is a paid consultant to BioMarin, Pfizer, QED, Ascendis. J. Hoover-Fong is a paid advisor to Biomarin, Pfizer, and Ascendis and receives grants from Biomarin. K. White is a paid consultant for BioMarin and receives grants from BioMarin, Ultragenyx, Pfizer, and Ascendis. M.B. Bober is a paid consultant for Biomarin, Pfizer, Ascendis, QED, Medlife Discoveries, and Alexion and receives research funding from Biomarin, Shire, Pfizer, Ascendis, QED, and Medlife Discoveries. A. Duker receives research funding from Potentials Foundation and Walking with Giants Foundation. J.M. Legare is a paid consultant for BioMarin and Ascendis and receives research funding from BioMarin and Ascendis.

Auteurs

Melissa A Villegas (MA)

University of Wisconsin School of Medicine and Public Health, 1500 Highland Avenue, Madison, WI 53705, USA.

Ericka Okenfuss (E)

Department of Genetics, Kaiser Permanente of Northern California, 1650 Response Road Kaiser, Sacramento, CA 95815, USA.

Ravi Savarirayan (R)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute and University of Melbourne, Parkville, Victoria 3052, Australia.

Klane White (K)

Seattle Children's, 4800 Sand Point Way, OA.9.120, Seattle, WA 98105, USA.

Julie Hoover-Fong (J)

Greenberg Center for Skeletal Dysplasias, McKusick Nathans Department of Genetic Medicine, Johns Hopkins University, 600 N. Wolfe Street, Blalock 1008, Baltimore, MD 21287, USA.

Michael B Bober (MB)

A.I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19803, USA.

Angela Duker (A)

A.I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19803, USA.

Janet M Legare (JM)

University of Wisconsin School of Medicine and Public Health, 1500 Highland Avenue, Madison, WI 53705, USA. Electronic address: jmlegare@pediatrics.wisc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH